# Knee Steroid Injection and Blood Sugar Signatur

> **NCT04317404** · — · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Diabetes
- Knee Osteoarthritis

## Interventions

- **DRUG:** 40 mg Triamcinolone acetonide

## Key facts

- **NCT ID:** NCT04317404
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317404, "Knee Steroid Injection and Blood Sugar Signatur". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT04317404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*